References
Hanrahan PS, Scrivens GA, Russell AS. Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 1989; 28: 147–53.
Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 1996; 39: 272–6.
Al-Awadhi A, Dale P, McKendry R Jr. Pancytopenia associated with low dose methotrexate therapy: A regional survey. J Rheumatol 1993; 20: 1121–5.
Rheumatoid Arthritis Clinical Trial Archive Group. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 1995; 22: 21823.
Maricic M, Davis M, Gall EP. Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprimsul-famethoxazole treatment. Arthritis Rheum 1986; 29: 133–5.
Brown MA, Corrigan AB. Pancytopenia after accidental over-dose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis. Med J Aust 1991; 155; 493–4.
Singh RR, Malaviya AN, Pandey JN, Guleria JS. Fatal interaction between methotrexate and naproxen. Lancet 1986; 1: 1390.
MacKinnon SK, Starkebaum G, Willkens RF. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthrits. Semin Arthritis Rheum 1985; 15: 119–26.
Omdal R, Goransson L, Bergrem H. Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis. Clin Rheumatol 1993; 12: 283–4.
Bruyn GAW, Velthuysen E, Joosten P, Houtman PM. Pancytopenia related eosinophilia in rheumatoid arthritis: A specific methotrexate phenomenon? J Rheumatol 1995; 22: 13716.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohosone, Y., Okano, Y., Kameda, H. et al. Clinical characteristics related to methotrexate-induced pancytopenia. Clin Rheumatol 16, 321–323 (1997). https://doi.org/10.1007/BF02238974
Issue Date:
DOI: https://doi.org/10.1007/BF02238974